deferoxamine and ecallantide

deferoxamine has been researched along with ecallantide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amati, M; Botta, GC; Carmignani, M; Fubini, B; Governa, M; Valentino, M; VisonĂ , I; Volpe, AR1
Amati, M; Astolfi, P; Bolognini, L; Carlo Botta, G; Carmignani, M; Coloccini, S; Emanuelli, M; Fenoglio, I; Fubini, B; Governa, M; Pierella, F; Valentino, M; Volpe, AR1

Other Studies

2 other study(ies) available for deferoxamine and ecallantide

ArticleYear
In vitro cleavage by asbestos fibers of the fifth component of human complement through free-radical generation and kallikrein activation.
    Journal of toxicology and environmental health. Part A, 2000, Apr-14, Volume: 59, Issue:7

    Topics: Adult; Antidotes; Asbestos; Asbestos, Crocidolite; Asbestos, Serpentine; Carcinogens; Chelating Agents; Chemotaxis; Complement C5; Complement C5a; Deferoxamine; Enzyme Activation; Female; Free Radical Scavengers; Free Radicals; Humans; Male; Middle Aged; Plasma Kallikrein; Thiourea

2000
Variability of biological effects of silicas: different degrees of activation of the fifth component of complement by amorphous silicas.
    Toxicology and applied pharmacology, 2005, Oct-01, Volume: 208, Issue:1

    Topics: Aprotinin; Chemotaxis, Leukocyte; Complement C5; Complement C5a; Crystallization; Deferoxamine; Deoxyribose; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Humans; Neutrophils; Oxidation-Reduction; Plasma Kallikrein; Silicon Dioxide; Spin Trapping; Thiourea; Zymosan

2005